Fri, Jul 25, 2014, 12:20 AM EDT - U.S. Markets open in 9 hrs 10 mins

Recent

% | $
Click the to save as a favorite.

CEL-SCI Corporation Message Board

  • yankeesnyc27 yankeesnyc27 Jul 30, 2013 4:02 AM Flag

    would you invest in this??

    "Under a separate pathway known as "accelerated approval" drugs may be approved based on a so-called surrogate endpoint - a measure, such as TUMOR SHRINKAGE - that might reasonably be expected to CONFER A CLINICAL BENEFIT SUCH AS IMPROVED SURVIVAL"

    LINK to complete article:http://news.yahoo.com/drugmakers-cheer-speed-lane-breakthrough-therapies-173049177.html The article is from REUTERS , NOT Cel-Sci .

    The bashers say Cel-Sci is going to ZERO, but then they say a lot of things and all of it is negative.

    Consider the following: If Cel-Sci went to zero who would lose the most $ ??

    Large investors have OVER $55 Million riding on the success of CVM.

    Add to that and additional $9 Million worth of shares as a part (75% ) of the Byron settlement , not to mention at least another $25 M for warrants.
    That adds up to at least $89 Million , PLUS the cost of shares they hold.

    My ( and your ) potential loss pales in comparison with their loss.

    It's their money that pays Geerts salary , the P3 , and in plain English, EVERYTHING else!

    Does anyone really think the bashers want to see Cel-Sci at $0??

    They have FAR more money at risk than ALL the share holders COMBINED ( 309M X .1861 = $57.5 M VS. $89M) . Add to their investment the cost of the shares they hold. 150 Million (?) @ .1861 = $27.9 M.

    I can take the loss , can they ???

    "THEY" are my insurance policy. "They" are a condom providing protection. :)

    Sentiment: Strong Buy

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
CVM
1.15-0.02(-1.71%)Jul 24 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.